[1] Hsu KC, Liu XR, Selvakumar A, et al. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets[J]. J Immunol, 2002, 169:5118-29. [2] Uhrberg M, Valiante NM, Shum BP, et al. Human diversity in killer cell inhibitory receptor genes[J]. Immunity, 1997, 7: 753-63. [3] Rajalingam R, Krausa P, Shilling HG, et al. Distinctive KIR and HLA diversity in a panel of north Indian Hindus [J]. Immunogen,2002, 53: 1009-19. [4] Yawata M, Yawata N, Mcqueen KL, et al. Predominance of group A KIR haplotypes in Japanese associated with diverse NK cell repertoires of KIR expression [J]. Immunogen, 2002, 54: 543-50. [5] Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity [J]. Annu Rev Immunol, 2002, 20:217-51. [6] Yen JH, Moore BE, Nakajima T, et al. Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis[J]. J Exp Med, 2001, 193(10): 1159-67. [7] Martin MP, Gao X, Lee JH, et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS [J]. Nat Genet, 2002, 31 (4): 429-34. [8] Guerra N, Guillard M, Angevin E, et al. Killer inhibitory receptor(CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas [J]. Blood, 2000, 95(9):2883-9. [9] Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants[J]. Science, 2002, 295(5562): 2097-100. [10] Martin MP, Nelson G, Lee JH, et al. Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles [J]. J Immunol,2002, 169(6): 2818-22. |